Nanoparticle-based RNA delivery has shown great progress in recent years with the
approval of two mRNA vaccines for Severe Acute Respiratory Syndrome Coronavirus 2 …

Over the past decade, circular RNA (circRNA) research has evolved into a bona fide
research field shedding light on the functional consequence of this unique family of RNA …

Abstract mRNA therapeutics have emerged as powerful tools for cancer immunotherapy in
accordance with their superiority in expressing all sequence‐known proteins in vivo. In …

The research and development of messenger RNA (mRNA) cancer vaccines have gradually
overcome numerous challenges through the application of personalized cancer antigens …

The introduction of more effective and selective mRNA delivery systems is required for the
advancement of many emerging biomedical technologies including the development of …

Compared to other types of tumor vaccines, RNA vaccines have emerged as promising
alternatives to conventional vaccine therapy due to their high efficiency, rapid development …

Vaccines play a critical role in the prevention of life-threatening infectious disease. However,
the development of effective vaccines against many immune-evading pathogens such as …

Circular RNAs (circRNAs) are stable RNAs present in cell-free RNA, which may comprise
cellular debris and pathogen genomes. Here, we investigate the phenomenon and …

Breast cancer's tendency to metastasize poses a critical barrier to effective treatment,
making it a leading cause of mortality among women worldwide. A growing body of …

Selective RNA delivery is required for the broad implementation of RNA clinical applications,
including prophylactic and therapeutic vaccinations, immunotherapies for cancer, and …